Posted by: Quit Smoking in Uncategorized
|
smoking vaccination not worth costHealth24.comTaking into account the effectiveness demonstrated so far by experimental vaccines designed to help smokers quit, the team concluded the drugs would need to be cheaper, require fewer doses and get better results for widespread preventive vaccination of ...and more » |
Tags: Drugs, Experimental Vaccines, Smokers, Smoking, Vaccination
Posted by: Quit Smoking in Uncategorized
|
Broad anti-smoking vaccination not worth cost: studyChicago TribuneTaking into account the effectiveness demonstrated so far by experimental vaccines designed to help smokers quit, the team concluded the drugs would need to be cheaper, require fewer doses and get better results for widespread preventive vaccination of ...and more » |
Tags: Anti Smoking, Chicago Tribune, Drugs, Experimental Vaccines, Smokers, Vaccination
Posted by: Quit Smoking in Uncategorized
|
Broad anti-smoking vaccination not worth cost: studyWTAQTaking into account the effectiveness demonstrated so far by experimental vaccines designed to help smokers quit, the team concluded the drugs would need to be cheaper, require fewer doses and get better results for widespread preventive vaccination of ... |
Tags: Anti Smoking, Drugs, Experimental Vaccines, Smokers, Vaccination
Posted by: Quit Smoking in Uncategorized
|
Broad anti-smoking vaccination not worth cost: studyBaltimore SunTaking into account the effectiveness demonstrated so far by experimental vaccines designed to help smokers quit, the team concluded the drugs would need to be cheaper, require fewer doses and get better results for widespread preventive vaccination of ... |
Tags: Anti Smoking, Baltimore Sun, Drugs, Experimental Vaccines, Smokers, Vaccination
Posted by: Quit Smoking in Uncategorized
|
Broad anti-smoking vaccination not worth cost: studyReutersTaking into account the effectiveness demonstrated so far by experimental vaccines designed to help smokers quit, the team concluded the drugs would need to be cheaper, require fewer doses and get better results for widespread preventive vaccination of ...and more » |
Tags: Anti Smoking, Drugs, Experimental Vaccines, Reuters, Smokers, Vaccination
Posted by: Quit Smoking in Uncategorized
NEW YORK (Reuters Health) - A vaccination campaign to prevent teenagers from taking up smoking would be too expensive to recommend, according to Australian researchers who looked at the costs and benefits of anti-nicotine shots in development. Taking into account the effectiveness demonstrated so far by experimental vaccines designed to help smokers quit, the team concluded the drugs would need ...
Tags: Anti Smoking, Australian Researchers, Drugs, Experimental Vaccines, Nicotine, Reuters Health, Smokers, Teenagers, Vaccination Campaign
Posted by: Quit Smoking in Uncategorized
LONDON, July 4 (Reuters) - Healthy, middle-aged smokers who take Pfizer's Chantix or Champix, one of the most popular quit-smoking drugs, have a higher risk of suffering heart attacks or other serious heart problems, a study found on Monday.
Tags: Champix, Chantix, Drugs, Heart Attacks, Heart Problems, Heart Risks, July 4, London, Pfizer, Quit Smoking, Reuters, Risk, Smokers, Smoking Risks, Suffering Heart
Posted by: Quit Smoking in Uncategorized
Tuesday, July 5th, 2011 14:13:00 LONDON: Healthy, middle-aged smokers who take Pfizer's Chantix or Champix, one of the most popular quit-smoking drugs, have a higher risk of suffering heart attacks or other serious heart problems, a study found on Monday.
Tags: Champix, Chantix, Drugs, Heart Attacks, Heart Problems, London, Pfizer, Quit Smoking, Risk, Smokers, Suffering Heart
Posted by: Quit Smoking in Uncategorized
Healthy, middle-aged smokers who take Pfizer's Chantix or Champix, one of the most popular quit-smoking drugs, have a higher risk of suffering heart attacks or other serious heart problems, a study found on Monday.
Tags: Champix, Chantix, Drugs, Heart Attacks, Heart Healthy, Heart Problems, Heart Risks, Pfizer, Quit Smoking, Risk, Smokers, Smoking Risks, Suffering Heart
Posted by: Quit Smoking in Uncategorized
LONDON (Reuters) - Healthy, middle-aged smokers who take Pfizer's Chantix or Champix, one of the most popular quit-smoking drugs, have a higher risk of suffering heart attacks or other serious heart problems, a study found on Monday.
Tags: Champix, Chantix, Drugs, Heart Attacks, Heart Healthy, Heart Problems, Heart Risks, London Reuters, Pfizer, Quit Smoking, Risk, Smokers, Smoking Risks, Suffering Heart